Publication | Open Access
High expression of ETS2 predicts poor prognosis in acute myeloid leukemia and may guide treatment decisions
31
Citations
33
References
2017
Year
Our results indicate that ETS2 <sup>high</sup> is a poor prognostic factor in AML and may guide treatment decisions towards allogeneic HCT.
| Year | Citations | |
|---|---|---|
Page 1
Page 1